Benjamín Ignacio Asencio Rojas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benjamín Ignacio Asencio Rojas has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Adrian P. Mundt
Centro de Investigación Biomédica, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile
2 shared publications - Pablo Antonio Cifuentes-Gramajo
Doctorado en Psicoterapia, Medical Faculties and Faculties of Social Sciences, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile
2 shared publications Antonio Morales-Rojas
Department of Psychiatry and Mental Health, Facultad de Medicina, Hospital Clínico Universidad de Chile, Santiago, Chile
1 shared publicationAriel Asencio-Rojas
Independent Researcher, Santiago, Chile
1 shared publication- Camila Solis-Araya
Programa de Salud Mental, Instituto de Salud Poblacional, Universidad de Chile, Santiago, Chile
1 shared publication - Cristian Flores-Peñailillo
Programa de Magíster en Bioestadística, Instituto de Salud Poblacional, Universidad de Chile, Santiago, Chile
1 shared publication
Latest Publications
- Open Access
- 8 October 2026
- Published by Springer Nature in Pilot and Feasibility Studies
Problem Management Plus (PM+) for common mental disorders in Chilean primary care: a feasibility randomized controlled trial of a transdiagnostic psychological intervention
Background: In Chile, more than one-third of the total disability burden is attributable to mental disorders, yet public mental health services in primary care present coverage gaps. This randomized controlled trial evaluated the feasibility, acceptability, and preliminary effects of Problem Management Plus (PM+) delivered individually by general health professionals in Chilean primary care. PM+ is a World Health Organization transdiagnostic psychological intervention that may help address these service gaps through task shifting. Methods: Adults ( n = 56) attending a public primary care center in Valdivia, Chile, with symptoms of depression and/or anxiety were randomized to PM+ ( n = 28) or treatment as usual (TAU) ( n = 28). Primary outcomes were feasibility (including recruitment and retention proportion, and adherence), fidelity (assessed with audio recordings), and acceptability (assessed with the Abbreviated Acceptability Rating Profile (AARP) and the Acceptability of Intervention Measure (AIM)). Secondary outcomes were the following clinical measures: depressive symptoms (measured with the Patient Health Questionnaire-9 Item (PHQ-9)), anxiety symptoms (Generalized Anxiety Disorder-7 Item (GAD-7)), and self-identified problems (Psychological Outcomes Profile (PSYCHLOPS)). Analyses of covariance (ANCOVA) were used to estimate adjusted effects, standardized using Hedges’ g. Results: The recruitment proportion was 67%, retention was 88%, and the adherence of participants averaged 4 PM+ sessions. PM+ achieved “sufficient” fidelity and was highly acceptable to participants (AARP mean: 43.6/48) and facilitators (AIM mean: 17.2/20). A total of 49 participants were analyzed at the post-intervention time point. With ANCOVA models adjusted for baseline scores and days to intervention initiation, PHQ-9 scores (depressive symptoms) were lower in the PM+ group than in the TAU group, although the difference was not statistically significant (7.4 vs. 10.3; p = 0.073, Hedges’ g = 0.54). GAD-7 scores (anxiety symptoms) were lower in the PM+ group, but no statistically significant difference was observed (7.1 vs. 7.5; p = 0.767, Hedges’ g = 0.09). PSYCHLOPS scores (intensity of self-identified problems) were significantly lower in the PM+ group (7.2 vs. 11.2; p = 0.006, Hedges’ g = 0.86). Conclusions: PM+ was feasible, acceptable, and showed moderate-to-large potential effects on self-identified problem intensity and depressive symptoms, supporting its suitability for larger-scale testing in Chile. Trial registration: ClinicalTrials.gov ID: NCT06988332 ( https://clinicaltrials.gov/study/NCT06988332 ). Registration was conducted before participant recruitment began. 2025-04-24.
- 8 October 2026
- Published by Springer Nature in Pilot and Feasibility Studies
Open AccessProblem Management Plus (PM+) for common mental disorders in Chilean primary care: a feasibility randomized controlled trial of a transdiagnostic psychological intervention
Background: In Chile, more than one-third of the total disability burden is attributable to mental disorders, yet public mental health services in primary care present coverage gaps. This randomized controlled trial evaluated the feasibility, acceptability, and preliminary effects of Problem Management Plus (PM+) delivered individually by general health professionals in Chilean primary care. PM+ is a World Health Organization transdiagnostic psychological intervention that may help address these service gaps through task shifting. Methods: Adults ( n = 56) attending a public primary care center in Valdivia, Chile, with symptoms of depression and/or anxiety were randomized to PM+ ( n = 28) or treatment as usual (TAU) ( n = 28). Primary outcomes were feasibility (including recruitment and retention proportion, and adherence), fidelity (assessed with audio recordings), and acceptability (assessed with the Abbreviated Acceptability Rating Profile (AARP) and the Acceptability of Intervention Measure (AIM)). Secondary outcomes were the following clinical measures: depressive symptoms (measured with the Patient Health Questionnaire-9 Item (PHQ-9)), anxiety symptoms (Generalized Anxiety Disorder-7 Item (GAD-7)), and self-identified problems (Psychological Outcomes Profile (PSYCHLOPS)). Analyses of covariance (ANCOVA) were used to estimate adjusted effects, standardized using Hedges’ g. Results: The recruitment proportion was 67%, retention was 88%, and the adherence of participants averaged 4 PM+ sessions. PM+ achieved “sufficient” fidelity and was highly acceptable to participants (AARP mean: 43.6/48) and facilitators (AIM mean: 17.2/20). A total of 49 participants were analyzed at the post-intervention time point. With ANCOVA models adjusted for baseline scores and days to intervention initiation, PHQ-9 scores (depressive symptoms) were lower in the PM+ group than in the TAU group, although the difference was not statistically significant (7.4 vs. 10.3; p = 0.073, Hedges’ g = 0.54). GAD-7 scores (anxiety symptoms) were lower in the PM+ group, but no statistically significant difference was observed (7.1 vs. 7.5; p = 0.767, Hedges’ g = 0.09). PSYCHLOPS scores (intensity of self-identified problems) were significantly lower in the PM+ group (7.2 vs. 11.2; p = 0.006, Hedges’ g = 0.86). Conclusions: PM+ was feasible, acceptable, and showed moderate-to-large potential effects on self-identified problem intensity and depressive symptoms, supporting its suitability for larger-scale testing in Chile. Trial registration: ClinicalTrials.gov ID: NCT06988332 ( https://clinicaltrials.gov/study/NCT06988332 ). Registration was conducted before participant recruitment began. 2025-04-24.
- Open Access
Incidence of all-cause mortality in prisons: research protocol for a global registry study and systematic literature review with meta-regression analyses
Introduction: People in prison experience disproportionate health burdens compared with community-based populations, including elevated rates of infectious and non-communicable diseases, mental illness and substance use disorders. Previous studies have consistently shown increased rates of mortality following release from incarceration, particularly from external (unnatural) causes such as suicide and violence. However, evidence on mortality incidence during imprisonment is scarce, and many deaths may be preventable through targeted health and prevention interventions. This study aims to synthesise worldwide evidence on all-cause mortality incidence in prisons. Methods and analysis: We will conduct a worldwide registry study combined with a systematic literature review and meta-regression analysis. Eligible sources will report deaths among incarcerated people between 2005 and 2025 at the national or, where more appropriate, the subnational jurisdictional level. Mortality data will be retrieved from official reports of prison administrations and direct contact with prison authorities. Also, data from international databases and the scientific literature will be reviewed. Incidence rates of all-cause mortality per 100 000 person-years will be calculated and reported for each jurisdiction, alongside standardised mortality ratios comparing imprisoned populations with general population estimates. Ethics and dissemination: Since the study relies on anonymised routine data registries available from different sources, an exemption certificate was granted by the Ethics Committee of Diego Portales University (UDP) in Santiago, Chile. Findings will be submitted for publication in a peer-reviewed academic journal. Trial registration number: https://osf.io/vkzae .
Open AccessIncidence of all-cause mortality in prisons: research protocol for a global registry study and systematic literature review with meta-regression analyses
Introduction: People in prison experience disproportionate health burdens compared with community-based populations, including elevated rates of infectious and non-communicable diseases, mental illness and substance use disorders. Previous studies have consistently shown increased rates of mortality following release from incarceration, particularly from external (unnatural) causes such as suicide and violence. However, evidence on mortality incidence during imprisonment is scarce, and many deaths may be preventable through targeted health and prevention interventions. This study aims to synthesise worldwide evidence on all-cause mortality incidence in prisons. Methods and analysis: We will conduct a worldwide registry study combined with a systematic literature review and meta-regression analysis. Eligible sources will report deaths among incarcerated people between 2005 and 2025 at the national or, where more appropriate, the subnational jurisdictional level. Mortality data will be retrieved from official reports of prison administrations and direct contact with prison authorities. Also, data from international databases and the scientific literature will be reviewed. Incidence rates of all-cause mortality per 100 000 person-years will be calculated and reported for each jurisdiction, alongside standardised mortality ratios comparing imprisoned populations with general population estimates. Ethics and dissemination: Since the study relies on anonymised routine data registries available from different sources, an exemption certificate was granted by the Ethics Committee of Diego Portales University (UDP) in Santiago, Chile. Findings will be submitted for publication in a peer-reviewed academic journal. Trial registration number: https://osf.io/vkzae .